38 results
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
and Israel, global geopolitical tensions, supply chain disruptions, rising interest rates and rising inflation;
our business strategies and goals … between Hamas and Israel, global geopolitical tensions, supply chain disruptions, rising interest rates and rising inflation;
our business strategies
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
between Hamas and Israel, global geopolitical tensions, supply chain disruptions, rising interest rates and rising inflation;
our business strategies … , such as the war in Ukraine and the state of war between Hamas and Israel, global geopolitical tensions, supply chain disruptions, rising interest
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
geopolitical tensions, supply chain disruptions, rising interest rates and rising inflation;
our business strategies and goals;
our plans to collaborate … macroeconomic factors, such as supply chain disruptions and rising inflation, may increase these expenses beyond what we currently anticipate. In recent months
6-K
EX-99.1
IMCR
Immunocore Holdings plc
7 Nov 23
Current report (foreign)
7:09am
fluctuations, and increases in commodity, energy and fuel prices as well as supply chain disruptions. The Board has concluded that while these may have
6-K
EX-99.2
IMCR
Immunocore Holdings plc
7 Nov 23
Current report (foreign)
7:09am
the product candidates in a sufficient quantity, including as a result of supply chain disruptions caused by pandemics or epidemics, the war in Ukraine … ; and encounter increased costs, difficulties collecting receivables from our customers, supply chain or other disruptions, or delays or other issues
6-K
EX-99.2
e4klztvkz wemjt6b1
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.1
7680tcq 7s
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.1
xklooc840
5 Jun 23
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
9:20am
6-K
iiw6x6mlz55pf
5 Jun 23
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
9:20am
6-K
EX-99.2
zfhggiz
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.1
8qs5iv8z3zfak
10 May 23
Current report (foreign)
7:27am
6-K
fw770dgu
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
EX-99.1
gd9j2
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
jrbjz44 8g19
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
EX-99.1
qo0 k55kwzize
8 Dec 22
Immunocore presents ovarian cancer expansion data for ImmTAC® candidate IMC-C103C targeting MAGE-A4
4:59pm
6-K
EX-99.1
pfa qbcw37
2 Dec 22
Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumors
5:08pm
6-K
9a7xyzpfh j1sf5nu3
14 Nov 22
Immunocore presents new biomarker analysis for KIMMTRAK (tebentafusp-tebn) in metastatic uveal melanoma at the SITC 2022 Annual Meeting
7:59am
6-K
EX-99.2
6wva dki3ao
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.4
4uk2b g7an
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am
6-K
EX-99.2
oxwfeh6mu0 znlw8p
10 Aug 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
8:00am